Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritis-Reference-Cited by-同舟云学术

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: Biologic and clinical implications in autoimmune arthritis

Published:2005 Issue:7 Volume:52 Page:2192-2201
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

de Rycke Leen,Baeten Dominique,Kruithof Elli,Van den Bosch Filip,Veys Eric M.,de Keyser Filip

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference46 articles.

1. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

2. Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies

3. TNFα as Therapeutic Target: New Drugs, More Applications

4. Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Lupus Cases Related to TNF Inhibitors in Children;The Journal of Pediatric Academy;2023-07-21

2. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07

3. Clinical use of anti-histone antibodies in idiopathic and drug-induced lupus;Immunological Medicine;2022-04-06

4. IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus;Lupus;2022-01-20

5. Practical management of patients on anti-TNF therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI);Joint Bone Spine;2021-05